US Patent Issued to Theriva Biologics on June 9 for "Alkaline phosphatase agents for treatment of radiation disorders" (Maryland Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,987, issued on June 9, was assigned to Theriva Biologics Inc. (Rockville, Md.).

"Alkaline phosphatase agents for treatment of radiation disorders" was invented by Michael Kaleko (Rockville, Md.), Christian Furlan Freguia (Rockville, Md.) and Sheila Connelly (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to, inter alia, compositions and methods, including therapeutic alkaline phosphatases that find use in the treatment or prevention of the effects of radiation exposure and/or chemotherapy."

The patent was filed on April 14, 2023, under Application No. 18/300,634.

*For further information, including image...